A further 10 drug categories were associated with at least three lead variants, including psychoactive drugs (muscle relaxants, psycholeptics, psychoanaleptics), treatments for metabolic syndrome and its comorbidities (diabetes drugs, lipid modifying agents, renin-angiotensin agents), and immune modulators (anti-asthmatics, anti-histamines). This evidence concerns the gene REN and metabolic syndrome.